A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma

Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study

(2021) Sylvie Bonvalot et al.   EJSO

Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas

(2021) Jules Lansu et al.   RADIOTHERAPY AND ONCOLOGY

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma

(2020) Jules Lansu et al.   JAMA Oncology

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

(2019) Sylvie Bonvalot et al.   LANCET ONCOLOGY

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2018) P G Casali et al.   ANNALS OF ONCOLOGY

Tumor necrosis and clinical outcomes following neoadjuvant therapy in soft tissue sarcoma: A systematic review and meta-analysis

(2018) Samer Salah et al.   CANCER TREATMENT REVIEWS

Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group Response Score

(2017) Inga-Marie Schaefer et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting

(2016) E. Wardelmann et al.   EUROPEAN JOURNAL OF CANCER

Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC – STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging

(2016) C. Messiou et al.   EUROPEAN JOURNAL OF CANCER

Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology

(2015) Jeremy R. Wortman et al.   EUROPEAN RADIOLOGY

Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma

(2014) D Andreou et al.   BRITISH JOURNAL OF CANCER

Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy

(2014) John T. Mullen et al.   CANCER

Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma

(2014) Max Vaynrub et al.   JOURNAL OF SURGICAL ONCOLOGY

Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus

(2013) Johannes L. Blaauwgeers et al.   VIRCHOWS ARCHIV

Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma

(2011) A. Gronchi et al.   ANNALS OF ONCOLOGY

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

(2010) Monique Maas et al.   LANCET ONCOLOGY

Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma

(2010) David Roberge et al.   RADIOTHERAPY AND ONCOLOGY

Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma

(2009) Peter W. M. Chung et al.   CANCER